相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Does tissue imprinting restrict macrophage plasticity?
Martin Guilliams et al.
NATURE IMMUNOLOGY (2021)
Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease
Stefan Schreiber et al.
GASTROENTEROLOGY (2021)
A myeloid-stromal niche and gp130 rescue in NOD2-driven Crohn's disease
Shikha Nayar et al.
NATURE (2021)
Gene Polymorphisms of NOD2, IL23R, PTPN2 and ATG16L1 in Patients with Crohn's Disease: On the Way to Personalized Medicine?
Peter Hoffmann et al.
GENES (2021)
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres et al.
JOURNAL OF CROHNS & COLITIS (2020)
Human Intestinal Mononuclear Phagocytes in Health and Inflammatory Bowel Disease
Charles Caer et al.
FRONTIERS IN IMMUNOLOGY (2020)
JAK-STAT pathway targeting for the treatment of inflammatory bowel disease
Azucena Salas et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Regulation of the Bone Marrow Niche by Inflammation
Ioannis Mitroulis et al.
FRONTIERS IN IMMUNOLOGY (2020)
The New Proactive Approach and Precision Medicine in Crohn's Disease
Eran Zittan et al.
BIOMEDICINES (2020)
Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II)
Silvio Danese et al.
GUT (2019)
Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn's Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study
Roy Frei et al.
JOURNAL OF CROHNS & COLITIS (2019)
Autologous stem cell transplantation in refractory Crohn's disease - low intensity therapy evaluation (ASTIClite): study protocols for a multicentre, randomised controlled trial and observational follow up study
John A. Snowden et al.
BMC GASTROENTEROLOGY (2019)
Intra- and Inter-cellular Rewiring of the Human Colon during Ulcerative Colitis
Christopher S. Smillie et al.
CELL (2019)
A Stromal Niche Defined by Expression of the Transcription Factor WT1 Mediates Programming and Homeostasis of Cavity-Resident Macrophages
Matthew B. Buechler et al.
IMMUNITY (2019)
Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy
Jerome C. Martin et al.
CELL (2019)
Personalised medicine in Crohn's disease
Nurulamin M Noor et al.
Lancet Gastroenterology & Hepatology (2019)
RICK/RIP2 is a NOD2-independent nodal point of gut inflammation
Tomohiro Watanabe et al.
INTERNATIONAL IMMUNOLOGY (2019)
Circuit Design Features of a Stable Two-Cell System
Xu Zhou et al.
CELL (2018)
OP021 Autologous haematopoietic stem cell transplantation for Crohn’s disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party
C Brierley et al.
Journal of Crohns & Colitis (2018)
Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease
James Kinchen et al.
CELL (2018)
Wilms' tumor 1 drives fibroproliferation and myofibroblast transformation in severe fibrotic lung disease
Vishwaraj Sontake et al.
JCI INSIGHT (2018)
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management
Fernando Gomollon et al.
JOURNAL OF CROHNS & COLITIS (2017)
Genome-Wide Association Study Identifies African-Specific Susceptibility Loci in African Americans With Inflammatory Bowel Disease
Steven R. Brant et al.
GASTROENTEROLOGY (2017)
Comparative Effectiveness of Mesalamine, Sulfasalazine, Corticosteroids, and Budesonide for the Induction of Remission in Crohn's Disease: A Bayesian Network Meta-analysis
Stephanie Coward et al.
INFLAMMATORY BOWEL DISEASES (2017)
The Future of Janus Kinase Inhibitors in Inflammatory Bowel Disease
L. C. S. De Vries et al.
JOURNAL OF CROHNS & COLITIS (2017)
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial
Jean-Frederic Colombel et al.
LANCET (2017)
Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease
Nathaniel R. West et al.
NATURE MEDICINE (2017)
Current and emerging therapeutic targets for IBD
Markus F. Neurath
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Induction of Colonic Regulatory T Cells by Mesalamine by Activating the Aryl Hydrocarbon Receptor
Kyoko Oh-oka et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
Ustekinumab for the treatment of Crohn's disease: can it find its niche?
Ebby G. Simon et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Designer Thiopurine-analogues for Optimised Immunosuppression in Inflammatory Bowel Diseases
Imke Atreya et al.
JOURNAL OF CROHNS & COLITIS (2016)
An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab
Tim Wyant et al.
JOURNAL OF CROHNS & COLITIS (2016)
Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease
B. G. Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis
Huanxing Sun et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Genetic influences on the Development of Fibrosis in Crohn's Disease
Bram Verstockt et al.
FRONTIERS IN MEDICINE (2016)
Macrophages in intestinal homeostasis and inflammation
Calum C. Bain et al.
IMMUNOLOGICAL REVIEWS (2014)
Vedolizumab for ulcerative colitis and crohns disease: results and implications of gemini studies
Mindy C. W. Lam et al.
IMMUNOTHERAPY (2014)
Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice
Calum C. Bain et al.
NATURE IMMUNOLOGY (2014)
Effect of Tumor Necrosis Factor-α Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease
Paolo Biancheri et al.
INFLAMMATORY BOWEL DISEASES (2013)
Mucosal Healing in Crohn's Disease: A Systematic Review
Peter De Cruz et al.
INFLAMMATORY BOWEL DISEASES (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins et al.
NATURE (2012)
Enhanced production of early lineages of monocytic and granulocytic cells in mice with colitis
Mark D. Trottier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Guidelines for the management of inflammatory bowel disease in adults
Craig Mowat et al.
GUT (2011)
Fibrocytes: emerging effector cells in chronic inflammation
Ronald A. Reilkoff et al.
NATURE REVIEWS IMMUNOLOGY (2011)
The Natural History of Adult Crohn's Disease in Population-Based Cohorts
Laurent Peyrin-Biroulet et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Monocyte Chemoattractant Protein-1 Contributes to Gut Homeostasis and Intestinal Inflammation by Composition of IL-10-Producing Regulatory Macrophage Subset
Yasuhiro Takada et al.
JOURNAL OF IMMUNOLOGY (2010)
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease.
Jean Frederic Colombel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Mucosal Healing Predicts Long-term Outcome of Maintenance Therapy with Infliximab in Crohn's Disease
Fabian Schnitzler et al.
INFLAMMATORY BOWEL DISEASES (2009)
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid
Carmine Stolfi et al.
BIOCHEMICAL PHARMACOLOGY (2008)
A randomized trial of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease
William J. Sandborn et al.
GASTROENTEROLOGY (2008)
The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to toll-like receptor ligands
Yun-Gi Kim et al.
IMMUNITY (2008)
Mesenchymal cell targeting by TNF as a common pathogenic principle in chronic inflammatory joint and intestinal diseases
Maria Armaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Traditional corticosteroids for induction of remission in Crohn's disease
E. Benchimol et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis
J. A. M. Wessels et al.
RHEUMATOLOGY (2008)
Review article: mechanisms of action of mesalazine in preventing colorectal carcinoma in inflammatory bowel disease
H Allgayer
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
NOD2/CARD15 does not influence response to infliximab in Crohn's disease
S Vermeire et al.
GASTROENTEROLOGY (2002)
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
SB Hanauer et al.
LANCET (2002)
Randomized, controlled trial of recombinant: human interleukin-11 in patients with active Crohn's disease
BE Sands et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2002)
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Y Ogura et al.
NATURE (2001)
A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
